UNSPSC 51431703: Libenzapril

This classification denotes an ace inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QD8496WWYK. European Medicines Agency schedules Libenzapril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08502MIG. Libenzapril generally arises in the molecular formula C18H25N3O5.

UNSPSC 51431703 Libenzapril is a Commodity code that covers pharmaceutical products for emergency medical use, specifically advanced life support medications supplied to municipal fire rescue and emergency medical services. State and local governments purchase these medications through sealed competitive bids to support emergency responder protocols and direct patient care. The City of Tampa's recent procurement exemplifies the scope: the city solicited sealed bids for four specific medication line items — Labetalol HCI, Epinephrine, Adenosine, and Diltiazem — with strict expiration-date and delivery requirements, all to supply Tampa Fire Rescue operations. Issuing bodies under this code include municipal fire departments and emergency services divisions; the recent activity shows municipal purchasing departments procuring directly on behalf of fire rescue units rather than through state health procurement channels.

The code shows limited recent activity. The City of Tampa's IFB (Bid No. 26P00188, due April 8, 2026, with an estimated contract value of $40,000) is the only recent state or local opportunity in the source data. The solicitation requires vendors to deliver medications within ten days of order receipt, maintain nine-month minimum expiration dates, and provide comprehensive Safety Data Sheets and WCAG 2.2 Level AA accessibility documentation. Tampa applied a 5 percent Small Local Business Enterprise bid discount (not to exceed $10,000) and reserved award rights by division or aggregate, with unilateral extension options up to three additional 30-day periods. The contract term runs one year from award with two optional one-year renewals. Geographic concentration appears limited to Florida based on the single recent posting; without additional opportunities in the block, assess demand under this code as low relative to broader pharmaceutical procurement for emergency medical services.